Viewing Study NCT04036461


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-01-05 @ 12:39 AM
Study NCT ID: NCT04036461
Status: TERMINATED
Last Update Posted: 2024-08-30
First Post: 2019-07-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module